Form 4 for ABT Abbott Laboratories
Accepted 2026-06-18 17:08:30 ET · period of report 2026-05-07 · accession 0001385262-26-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-18 17:08 | 2026-05-07 | ABT | Stratton John G | Dir | P - Purchase | $86.82 | +2,000 | 23.3K | +9% | +$173.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2026-05-07 | P | A | 2,000 | $86.82 | 23,319 | D | — | — |